Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20852327rdf:typepubmed:Citationlld:pubmed
pubmed-article:20852327lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:20852327lifeskim:mentionsumls-concept:C0015684lld:lifeskim
pubmed-article:20852327lifeskim:mentionsumls-concept:C0023779lld:lifeskim
pubmed-article:20852327lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:20852327lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:20852327lifeskim:mentionsumls-concept:C0243144lld:lifeskim
pubmed-article:20852327lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:20852327lifeskim:mentionsumls-concept:C1521975lld:lifeskim
pubmed-article:20852327lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:20852327pubmed:issue49lld:pubmed
pubmed-article:20852327pubmed:dateCreated2010-11-29lld:pubmed
pubmed-article:20852327pubmed:abstractTextLipids circulate in the blood in association with plasma lipoproteins and enter the tissues either after hydrolysis or as non-hydrolyzable lipid esters. We studied cardiac lipids, lipoprotein lipid uptake, and gene expression in heart-specific lipoprotein lipase (LpL) knock-out (hLpL0), CD36 knock-out (Cd36(-/-)), and double knock-out (hLpL0/Cd36(-/-)-DKO) mice. Loss of either LpL or CD36 led to a significant reduction in heart total fatty acyl-CoA (control, 99.5 ± 3.8; hLpL0, 36.2 ± 3.5; Cd36(-/-), 57.7 ± 5.5 nmol/g, p < 0.05) and an additive effect was observed in the DKO (20.2 ± 1.4 nmol/g, p < 0.05). Myocardial VLDL-triglyceride (TG) uptake was reduced in the hLpL0 (31 ± 6%) and Cd36(-/-) (47 ± 4%) mice with an additive reduction in the DKO (64 ± 5%) compared with control. However, LpL but not CD36 deficiency decreased VLDL-cholesteryl ester uptake. Endogenously labeled mouse chylomicrons were produced by tamoxifen treatment of ?-actin-MerCreMer/LpL(flox/flox) mice. Induced loss of LpL increased TG levels >10-fold and reduced HDL by >50%. After injection of these labeled chylomicrons in the different mice, chylomicron TG uptake was reduced by ?70% and retinyl ester by ?50% in hLpL0 hearts. Loss of CD36 did not alter either chylomicron TG or retinyl ester uptake. LpL loss did not affect uptake of remnant lipoproteins from ApoE knock-out mice. Our data are consistent with two pathways for fatty acid uptake; a CD36 process for VLDL-derived fatty acid and a non-CD36 process for chylomicron-derived fatty acid uptake. In addition, our data show that lipolysis is involved in uptake of core lipids from TG-rich lipoproteins.lld:pubmed
pubmed-article:20852327pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:languageenglld:pubmed
pubmed-article:20852327pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:citationSubsetIMlld:pubmed
pubmed-article:20852327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852327pubmed:statusMEDLINElld:pubmed
pubmed-article:20852327pubmed:monthDeclld:pubmed
pubmed-article:20852327pubmed:issn1083-351Xlld:pubmed
pubmed-article:20852327pubmed:authorpubmed-author:GoldbergIra...lld:pubmed
pubmed-article:20852327pubmed:authorpubmed-author:ShulmanGerald...lld:pubmed
pubmed-article:20852327pubmed:authorpubmed-author:HuYunyingYlld:pubmed
pubmed-article:20852327pubmed:authorpubmed-author:AbumradNada...lld:pubmed
pubmed-article:20852327pubmed:authorpubmed-author:RamakrishnanR...lld:pubmed
pubmed-article:20852327pubmed:authorpubmed-author:BlanerWilliam...lld:pubmed
pubmed-article:20852327pubmed:authorpubmed-author:HiyamaYaekoYlld:pubmed
pubmed-article:20852327pubmed:authorpubmed-author:HugginsLesley...lld:pubmed
pubmed-article:20852327pubmed:authorpubmed-author:BharadwajKaly...lld:pubmed
pubmed-article:20852327pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20852327pubmed:day3lld:pubmed
pubmed-article:20852327pubmed:volume285lld:pubmed
pubmed-article:20852327pubmed:ownerNLMlld:pubmed
pubmed-article:20852327pubmed:authorsCompleteYlld:pubmed
pubmed-article:20852327pubmed:pagination37976-86lld:pubmed
pubmed-article:20852327pubmed:dateRevised2011-3-30lld:pubmed
pubmed-article:20852327pubmed:meshHeadingpubmed-meshheading:20852327...lld:pubmed
pubmed-article:20852327pubmed:meshHeadingpubmed-meshheading:20852327...lld:pubmed
pubmed-article:20852327pubmed:meshHeadingpubmed-meshheading:20852327...lld:pubmed
pubmed-article:20852327pubmed:meshHeadingpubmed-meshheading:20852327...lld:pubmed
pubmed-article:20852327pubmed:meshHeadingpubmed-meshheading:20852327...lld:pubmed
pubmed-article:20852327pubmed:meshHeadingpubmed-meshheading:20852327...lld:pubmed
pubmed-article:20852327pubmed:meshHeadingpubmed-meshheading:20852327...lld:pubmed
pubmed-article:20852327pubmed:meshHeadingpubmed-meshheading:20852327...lld:pubmed
pubmed-article:20852327pubmed:meshHeadingpubmed-meshheading:20852327...lld:pubmed
pubmed-article:20852327pubmed:meshHeadingpubmed-meshheading:20852327...lld:pubmed
pubmed-article:20852327pubmed:meshHeadingpubmed-meshheading:20852327...lld:pubmed
pubmed-article:20852327pubmed:meshHeadingpubmed-meshheading:20852327...lld:pubmed
pubmed-article:20852327pubmed:meshHeadingpubmed-meshheading:20852327...lld:pubmed
pubmed-article:20852327pubmed:meshHeadingpubmed-meshheading:20852327...lld:pubmed
pubmed-article:20852327pubmed:year2010lld:pubmed
pubmed-article:20852327pubmed:articleTitleChylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake.lld:pubmed
pubmed-article:20852327pubmed:affiliationDivision of Preventive Medicine and Nutrition, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.lld:pubmed
pubmed-article:20852327pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20852327pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20852327pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:12491entrezgene:pubmedpubmed-article:20852327lld:entrezgene
entrez-gene:16956entrezgene:pubmedpubmed-article:20852327lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20852327lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20852327lld:pubmed